Overexpression of the mTOR alpha4 phosphoprotein activates protein phosphatase 2A and increases Stat1α binding to PIAS1

被引:20
作者
Nien, Wei Lun
Dauphinee, Shauna M.
Moffat, Lori D.
Too, Catherine K. L.
机构
[1] Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Dept Obstet & Gynecol, Fac Med, Halifax, NS B3H 1X5, Canada
基金
加拿大健康研究院;
关键词
mTOR alpha4 phosphoprotein; PRL; PP2A; Stat1; alpha; PIAS1;
D O I
10.1016/j.mce.2006.08.015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alpha4 phosphoprotein in the mTOR pathway is a prolactin (PRL)-downregulated gene product that interacts with the catalytic subunit of serine/threonine protein phosphatase 2A (PP2Ac) in rat Nb2 lymphoma cells. Transient overexpression of alpha4 in COS-1 cells inhibited PRL-inducible interferon-regulatory-1 (IRF-1) promoter activity, but the mechanism underlying this inhibition was not known. The present study showed a stable alpha4-PP2Ac complex that was not dissociated by rapamycin in COS-I cells. Transient overexpression of alpha4 in COS-I cells had no effect on endogenous PP2Ac protein levels but significantly increased PP2Ac carboxymethylation and PP2A activity as compared to controls. The increased PP2A activity was accompanied by decreased phosphorylation of eukaryotic initiation factor 4E-bindin-protein (4E-BPI) but had no effect on Stat phosphorylation. However, overexpressed alpha4 decreased argainine methylation of Stat1 alpha and increased Stat1 alpha. binding to the Stat1 alpha-specific inhibitor, PIAS1. In summary, ectopic alpha4 increased PP2A activity in COS-1 cells and this was accompanied by Stat1 alpha hypornethylation and increased Stat1 alpha-PIAS1 association. These events would inhibit Stat action and ultimately inhibit PRL-inducible IRF-1 promoter activity. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 42 条
[1]  
Bishop JD, 2006, J ENDOCRINOL, V190, P307, DOI 10.1677/joe.1.06368
[2]   The TOR pathway: A target for cancer therapy [J].
Bjornsti, MA ;
Houghton, PJ .
NATURE REVIEWS CANCER, 2004, 4 (05) :335-348
[3]   Implication of α4 phosphoprotein and the rapamycin-sensitive mammalian target-of-rapamycin pathway in prolactin receptor signalling [J].
Boudreau, RTM ;
Sangster, SM ;
Johnson, LM ;
Dauphinee, S ;
Li, AW ;
Too, CKL .
JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) :493-506
[4]   Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Bα subunit [J].
Bryant, JC ;
Westphal, RS ;
Wadzinski, BE .
BIOCHEMICAL JOURNAL, 1999, 339 :241-246
[5]   α4 associates with protein phosphatases 2A, 4, and 6 [J].
Chen, J ;
Peterson, RT ;
Schreiber, SL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :827-832
[6]   Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the α4 subunit which promotes dephosphorylation of elongation factor-2 [J].
Chung, HY ;
Nairn, AC ;
Murata, K ;
Brautigan, DL .
BIOCHEMISTRY, 1999, 38 (32) :10371-10376
[7]   Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins [J].
Clemens, MJ .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2001, 5 (03) :221-239
[8]   Prolactin receptor signal transduction in cells of the immune system [J].
Clevenger, CV ;
Freier, DO ;
Kline, JB .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (02) :187-197
[9]   TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals [J].
Cutler, NS ;
Heitman, J ;
Cardenas, ME .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 155 (1-2) :135-142
[10]   Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases [J].
DiComo, CJ ;
Arndt, KT .
GENES & DEVELOPMENT, 1996, 10 (15) :1904-1916